Related Experiment Video
Updated: Oct 20, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Analytical method validation for biomarkers as a drug development tool: points to consider.
Yoshiaki Ohtsu1, Seiji Tanaka2, Harue Igarashi3
1Kyowa Kirin Co., Ltd. 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan.
Regulatory guidelines in Japan lack standards for validating biomarker analytical methods. This document provides recommendations for validating biomarker assays, aiming for global harmonization in drug development.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Regulatory Science
Background:
- Biomarkers are crucial tools in drug development for assessing efficacy and adverse reactions.
- Current regulatory documents in Japan do not specify requirements for validating quantitative analytical methods for biomarkers.
- Validated biomarker assays are essential for reliable clinical evaluations and post-marketing surveillance.
Purpose of the Study:
- To address the absence of regulatory guidelines for biomarker analytical method validation in Japan.
- To provide a 'points to consider' document for the validation of biomarker assays.
- To contribute to the global harmonization of biomarker assay validation standards.
Main Methods:
- The Biomarker Analytical Method Validation Study Group, comprising industry and regulatory experts, convened to discuss and prepare the document.
- The document covers validation aspects for endogenous metabolites, peptides, and proteins.
- Specific analytical techniques discussed include ligand binding assays and chromatographic methods (with or without mass spectrometry).
Main Results:
- A comprehensive 'points to consider' document has been prepared by the study group.
- The document offers guidance on validating various biomarker measurement techniques.
- It addresses the critical need for standardized validation processes in Japan.
Conclusions:
- Establishing clear guidelines for biomarker analytical method validation is crucial for drug development in Japan.
- The prepared document serves as a foundational resource for industry and regulatory bodies.
- Harmonizing validation practices will enhance the reliability and global acceptance of biomarker data.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Therapeutic Drug Monitoring: Drug Analysis Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Development of Analytical Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability Study Design: Healthy Subjects Versus Patients

